英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字,中文词皆可:



安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • Home - Mirum Pharma
    Developing medicines with the potential to change lives Creating transformative medicine for rare liver diseas
  • Mirum Pharmaceuticals, Inc. - Investor Relations
    March 12, 2026 Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635 (c) (4) March 5, 2026 Mirum Pharmaceuticals Completes AZURE-1 Enrollment and AZURE-4 Screening in Phase 3 Program of brelovitug in Chronic Hepatitis Delta Virus View All News
  • About Us - Mirum Pharma
    We are committed to developing safe and effective therapies for people with rare liver diseases Ultimately, we want to help patients and their families experience a brighter future
  • Mirum Pharmaceuticals, Inc. - News
    Mirum Pharmaceuticals Completes Acquisition of Bluejay Therapeutics, Expanding Global Leadership in Rare Disease Mirum Pharmaceuticals Announces Preliminary Unaudited 2025 Results, Demonstrating Strong Commercial Growth and Pipeline Momentum Mirum Pharmaceuticals to Present at the 44th Annual J P Morgan Healthcare Conference
  • Leadership Team - Mirum Pharma
    Here at Mirum, we have brought together some of the top experts in liver disease and pharmaceutical development It is with passion, insight, and collective experience that we’re pushing the boundaries of what is possible
  • Our Discoveries - Mirum Pharma
    Impacting the lives of those living with rare liver disease is more than a mission—it’s our calling At Mirum, our work is in service of closing treatment gaps to open a world of possibilities for patients and their families
  • Contact Us - Mirum Pharma
    Patient Stories Resources Mirum Library Our Medicines LIVMARLI LIVMARLI Availability LIVMARLI in the U S LIVMARLI in the E U Mirum Access Plus (MAP) Cholbam CTEXLI Life at Mirum The Mirum Experience Join Our Circle Investors Overview News Events Financials Stock Stock Quote Chart Historical Price Lookup Analyst Coverage Corporate
  • Mirum Pharmaceuticals, Inc. - Mirum Pharmaceuticals Completes . . .
    FOSTER CITY, Calif -- (BUSINESS WIRE)-- Mirum Pharmaceuticals, Inc (NASDAQ: MIRM), a leading rare disease company, today announced the successful completion of its acquisition of Bluejay Therapeutics, a privately held biotechnology company focused on viral and liver diseases With the completion of the acquisition, Mirum adds worldwide rights to brelovitug, a late-stage, fully human
  • The Mirum Experience - Mirum Pharma
    At Mirum, we’re proud that our expertise covers a wide range of disciplines within rare disease and pharmaceutical drug development Our deep experience spans early-stage research, clinical trials, regulatory approval, and commercialization In fact, many of us have worked closely together on other successful biotechnology and pharmaceutical ventures The chemistry we have with each other
  • Our Science - Mirum Pharma
    Our passion for science and our desire to serve people is what motivates and inspires us That’s why we are developing potentially life-changing medicines for people with rare liver disease





中文字典-英文字典  2005-2009